Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
BÀI TỔNG QUAN Issue: Số 109 TĂNG HUYẾT ÁP

Update on hypertension management in the elderly

Ngô Hoàng Toàn: Trường Đại học Y Dược Cần Thơ; Trần Kim Sơn: Trường Đại học Y Dược Cần Thơ; Huỳnh Văn Minh: Hội Tim mạch học Việt Nam;
Published: May 31, 2024
Views: 199

Abstract

Hypertension and the aging process have garnered increasing attention, especially considering the rising prevalence of hypertension among the elderly population. Significant updates regarding diagnostic thresholds, treatment interventions, and management strategies for hypertension in the elderly have been outlined by the European Society of Hypertension (ESH) in 2023. For individuals aged 65-79 without isolated systolic hypertension, the treatment goal is to achieve blood pressure <140/80 mmHg, with isolated systolic hypertension targeted at maintaining systolic blood pressure between 140-150 mmHg. For those aged 80 and above, the treatment aim is to maintain blood pressure between 140-150 mmHg for systolic blood pressure and <80 mmHg for diastolic blood pressure, without lowering it below 120/70 mmHg. Patients of very older with systolic blood pressure <120 mmHg or severe frailty may consider reducing antihypertensive therapy.

References

1.
Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;107(22):2864-2869. doi:10.1161/01.CIR.0000069826.36125.B4
2.
Abellan van Kan G, Rolland Y, Bergman H, et al. The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging. 2008;12(1):29-37. doi:10.1007/BF02982161
3.
Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874-2071. doi:10.1097/HJH.0000000000003480
4.
Shantsila E, Lip GYH, Shantsila A, et al. Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?. J Hypertens. 2023;41(10):1502-1510. doi:10.1097/HJH.0000000000003495
5.
Zhang W, Zhang S, Deng Y, et al. Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. N Engl J Med. 2021;385(14):1268-1279. doi:10.1056/NEJMoa2111437
6.
Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. JAMA. 2016;315(24):2673-2682. doi:10.1001/jama.2016.7050
7.
Mancia G, Kjeldsen SE, Kreutz R, et al. Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines. Hypertension. 2022;79(6):1153-1166. doi:10.1161/HYPERTENSIONAHA.122.19020
8.
Riemer TG, Villagomez Fuentes LE, Algharably EAE, et al. Do β-Blockers Cause Depression?: Systematic Review and Meta-Analysis of Psychiatric Adverse Events During β-Blocker Therapy. Hypertension. 2021;77(5):1539-1548. doi:10.1161/HYPERTENSIONAHA.120.16590
9.
Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887-1898. doi:10.1056/NEJMoa0801369

Files

Article Views199
Document Views0
Downloads0
Section BÀI TỔNG QUAN
Issue Số 109
Category TĂNG HUYẾT ÁP